Integral Ad Science (NASDAQ:IAS) Hits New 52-Week Low Following Insider Selling

Shares of Integral Ad Science Holding Corp. (NASDAQ:IASGet Free Report) reached a new 52-week low during trading on Wednesday following insider selling activity. The stock traded as low as $8.58 and last traded at $8.58, with a volume of 15871 shares. The stock had previously closed at $9.90.

Specifically, CEO Lisa Utzschneider sold 8,044 shares of the stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $9.97, for a total value of $80,198.68. Following the completion of the sale, the chief executive officer now owns 203,139 shares of the company’s stock, valued at approximately $2,025,295.83. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, CEO Lisa Utzschneider sold 8,044 shares of the business’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $9.97, for a total transaction of $80,198.68. Following the transaction, the chief executive officer now directly owns 203,139 shares in the company, valued at approximately $2,025,295.83. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Alexis Gil II sold 3,177 shares of the firm’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $10.24, for a total transaction of $32,532.48. Following the completion of the sale, the chief accounting officer now owns 120,195 shares of the company’s stock, valued at $1,230,796.80. The disclosure for this sale can be found here. Insiders have sold 75,126 shares of company stock valued at $749,707 in the last 90 days. 2.00% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the company. Bank of America assumed coverage on Integral Ad Science in a report on Thursday, January 11th. They set a “buy” rating and a $19.00 target price on the stock. Raymond James lowered shares of Integral Ad Science from a “strong-buy” rating to an “outperform” rating and dropped their price objective for the company from $20.00 to $16.00 in a research report on Wednesday, February 28th. Barclays cut their target price on shares of Integral Ad Science from $16.00 to $12.00 and set an “equal weight” rating for the company in a research note on Monday, April 15th. Loop Capital assumed coverage on shares of Integral Ad Science in a research note on Tuesday, April 30th. They issued a “buy” rating and a $15.00 price target on the stock. Finally, Morgan Stanley restated an “equal weight” rating and set a $12.00 price objective (down from $18.00) on shares of Integral Ad Science in a research report on Tuesday, April 16th. Three research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $17.38.

View Our Latest Stock Analysis on Integral Ad Science

Integral Ad Science Stock Down 15.5 %

The company has a debt-to-equity ratio of 0.17, a quick ratio of 3.21 and a current ratio of 3.21. The stock’s fifty day simple moving average is $9.70 and its two-hundred day simple moving average is $12.84. The stock has a market capitalization of $1.34 billion, a P/E ratio of 206.05, a price-to-earnings-growth ratio of 1.72 and a beta of 1.58.

Integral Ad Science (NASDAQ:IASGet Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.03. The company had revenue of $134.30 million for the quarter, compared to analysts’ expectations of $131.27 million. Integral Ad Science had a net margin of 1.53% and a return on equity of 0.83%. Integral Ad Science’s revenue for the quarter was up 14.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.07 earnings per share. As a group, research analysts expect that Integral Ad Science Holding Corp. will post 0.16 EPS for the current fiscal year.

Institutional Investors Weigh In On Integral Ad Science

Several institutional investors and hedge funds have recently made changes to their positions in IAS. Goldman Sachs Group Inc. lifted its stake in shares of Integral Ad Science by 605.1% in the fourth quarter. Goldman Sachs Group Inc. now owns 2,740,011 shares of the company’s stock worth $39,429,000 after acquiring an additional 2,351,414 shares during the period. abrdn plc acquired a new position in shares of Integral Ad Science in the 4th quarter worth approximately $25,285,000. Vanguard Group Inc. boosted its stake in shares of Integral Ad Science by 15.2% in the 3rd quarter. Vanguard Group Inc. now owns 7,325,778 shares of the company’s stock valued at $87,104,000 after purchasing an additional 966,280 shares during the last quarter. P2 Capital Partners LLC acquired a new stake in shares of Integral Ad Science during the fourth quarter worth $11,144,000. Finally, TimesSquare Capital Management LLC raised its stake in Integral Ad Science by 32.2% during the third quarter. TimesSquare Capital Management LLC now owns 2,486,748 shares of the company’s stock worth $29,567,000 after buying an additional 605,824 shares during the last quarter. Institutional investors and hedge funds own 95.78% of the company’s stock.

About Integral Ad Science

(Get Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Recommended Stories

Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.